[1]
Mountzias, A. et al. 2022. Inflammatory response markers and survival prediction in patients with renal cell carcinoma. Scandinavian Journal of Urology. 56, 1 (Jan. 2022), 47–52. DOI:https://doi.org/10.1080/21681805.2021.1983016.